K6 (Clonazepam (dispersible) 0.25 mg)

Pill imprint K6 has been identified as Clonazepam (dispersible) 0.25 mg.

Clonazepam is used in the treatment of anxiety; benzodiazepine withdrawal; bipolar disorder; panic disorder; borderline personality disorder (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Clonazepam (dispersible)

Imprint:

K6

Strength:

0.25 mg

Color:

White

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Benzodiazepine anticonvulsants
Benzodiazepines

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

4 - Some potential for abuse

Manufacturer:

Par Pharmaceutical Inc.

National Drug Code (NDC):

49884-0307

Inactive Ingredients:

aspartame
crospovidone
magnesium stearate
mannitol
silicon dioxide
sorbitol
sodium lauryl sulfate
magnesium silicate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.